These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 33987813)

  • 1. Drug Repurposing: A Network-based Approach to Amyotrophic Lateral Sclerosis.
    Fiscon G; Conte F; Amadio S; Volonté C; Paci P
    Neurotherapeutics; 2021 Jul; 18(3):1678-1691. PubMed ID: 33987813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitro.
    Duan QQ; Wang H; Su WM; Gu XJ; Shen XF; Jiang Z; Ren YL; Cao B; Li GB; Wang Y; Chen YP
    BMC Med; 2024 Mar; 22(1):96. PubMed ID: 38443977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced pluripotent stem cell-based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis patients.
    Imamura K; Izumi Y; Banno H; Uozumi R; Morita S; Egawa N; Ayaki T; Nagai M; Nishiyama K; Watanabe Y; Hanajima R; Oki R; Fujita K; Takahashi N; Ikeda T; Shimizu A; Morinaga A; Hirohashi T; Fujii Y; Takahashi R; Inoue H
    BMJ Open; 2019 Dec; 9(12):e033131. PubMed ID: 31796494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
    Fiscon G; Conte F; Farina L; Paci P
    PLoS Comput Biol; 2021 Feb; 17(2):e1008686. PubMed ID: 33544720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Integrative Transcriptome-Wide Analysis of Amyotrophic Lateral Sclerosis for the Identification of Potential Genetic Markers and Drug Candidates.
    Park S; Kim D; Song J; Joo JWJ
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signature-Based Computational Drug Repurposing for Amyotrophic Lateral Sclerosis.
    Papikinos T; Krokidis MG; Vrahatis A; Vlamos P; Exarchos TP
    Adv Exp Med Biol; 2023; 1424():201-211. PubMed ID: 37486495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potentially functional modules and diagnostic genes related to amyotrophic lateral sclerosis based on the WGCNA and LASSO algorithms.
    Daneshafrooz N; Bagherzadeh Cham M; Majidi M; Panahi B
    Sci Rep; 2022 Nov; 12(1):20144. PubMed ID: 36418457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histaminergic transmission slows progression of amyotrophic lateral sclerosis.
    Apolloni S; Amadio S; Fabbrizio P; Morello G; Spampinato AG; Latagliata EC; Salvatori I; Proietti D; Ferri A; Madaro L; Puglisi-Allegra S; Cavallaro S; Volonté C
    J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):872-893. PubMed ID: 31020811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omics-based exploration and functional validation of neurotrophic factors and histamine as therapeutic targets in ALS.
    Volonté C; Morello G; Spampinato AG; Amadio S; Apolloni S; D'Agata V; Cavallaro S
    Ageing Res Rev; 2020 Sep; 62():101121. PubMed ID: 32653439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposing Histaminergic Drugs in Multiple Sclerosis.
    Amadio S; Conte F; Esposito G; Fiscon G; Paci P; Volonté C
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35683024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can Some Anticancer Drugs Be Repurposed to Treat Amyotrophic Lateral Sclerosis? A Brief Narrative Review.
    Potenza RL; Armida M; Popoli P
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Expression of MicroRNAs and Predicted Drug Target in Amyotrophic Lateral Sclerosis.
    Patel RB; Bajpai AK; Thirumurugan K
    J Mol Neurosci; 2023 Jun; 73(6):375-390. PubMed ID: 37249795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network Pharmacology and Molecular Docking to Unveil the Mechanism of Shudihuang against Amyotrophic Lateral Sclerosis.
    Li X; Tian Y; Wu H; Wang T
    Curr Pharm Des; 2023; 29(19):1535-1545. PubMed ID: 37345246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs in clinical development for the treatment of amyotrophic lateral sclerosis.
    Martinez A; Palomo Ruiz MD; Perez DI; Gil C
    Expert Opin Investig Drugs; 2017 Apr; 26(4):403-414. PubMed ID: 28277881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Potential Repurposable Drugs in Alzheimer's Disease Exploiting a Bioinformatics Analysis.
    Fiscon G; Sibilio P; Funari A; Conte F; Paci P
    J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SAveRUNNER: an R-based tool for drug repurposing.
    Fiscon G; Paci P
    BMC Bioinformatics; 2021 Mar; 22(1):150. PubMed ID: 33757425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapeutic agent 5-fluorouracil increases survival of SOD1 mouse model of ALS.
    Rando A; de la Torre M; Martinez-Muriana A; Zaragoza P; Musaro A; Hernández S; Navarro X; Toivonen JM; Osta R
    PLoS One; 2019; 14(1):e0210752. PubMed ID: 30640943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network controllability solutions for computational drug repurposing using genetic algorithms.
    Popescu VB; Kanhaiya K; Năstac DI; Czeizler E; Petre I
    Sci Rep; 2022 Jan; 12(1):1437. PubMed ID: 35082323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network-based approach for targeting human kinases commonly associated with amyotrophic lateral sclerosis and cancer.
    Khatoon F; Haque S; Hashem A; Mahmoud A; Tashkandi H; Mathkor D; Harakeh S; Alghamdi B; Kumar V
    Front Mol Neurosci; 2022; 15():1023286. PubMed ID: 36590916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Amyotrophic lateral sclerosis, a heterogeneous disorder].
    van Es MA; Kruitwagen-van Reenen ET; Schröder CD; Pasterkamp RJ; Veldink JH; van den Berg LH
    Ned Tijdschr Geneeskd; 2016; 160():A9658. PubMed ID: 26860749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.